Historical record - last NADAC effective date: 9/18/2024
Product Information
CLOPIDOGREL 75 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0626 per EA under NDC 47335089413. Its NADAC has been published 568 times since Nov 28, 2013.
FDA first approved this application on May 17, 2012.
Strength
75 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335089413
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA090494FDA Approved
5/17/2012
On Market Since
5/18/2012
Pharmacological Classes
Price Statistics
The NADAC for CLOPIDOGREL 75 MG TABLET has been published 568 times since Nov 28, 2013, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0626 per EA |
|---|---|
| All-time high | $0.1276 (Feb 12, 2014) |
| All-time low | $0.0558 (May 22, 2024) |
| Median price | $0.0655 |
| Average price | $0.0730 |
| Largest weekly change | +20.1% (Jan 22, 2014) |
| Weeks tracked | 568 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.2%
5Y
-4.4%
All
-42.3%
Last surveyed Oct 9, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clopidogrel Bisulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOPIDOGREL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOPIDOGREL 75 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0626 per EA (NDC 47335089413), effective Oct 9, 2024.
How has the price of CLOPIDOGREL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOPIDOGREL 75 MG TABLET has declined 42.3%. It has been tracked across 568 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOPIDOGREL 75 MG TABLET?
Since Nov 28, 2013, the NADAC for CLOPIDOGREL 75 MG TABLET has ranged from a low of $0.0558 (May 22, 2024) to a high of $0.1276 (Feb 12, 2014), with a median of $0.0655 per EA.
Are there cheaper alternatives to CLOPIDOGREL 75 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOPIDOGREL 75 MG TABLET, is $0.0472 per EA — about 25% below CLOPIDOGREL 75 MG TABLET.
Who manufactures CLOPIDOGREL 75 MG TABLET?
CLOPIDOGREL 75 MG TABLET (NDC 47335089413) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.